有症状隐球菌抗原血症表现为脑脊液阴性的早期隐球菌性脑膜炎
BACKGROUND: Individuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection to cryptococcal meningitis is unclear.…
要点
- 有症状隐球菌抗原血症占疑似脑膜炎患者的4%,为第三常见病因。
- 氟康唑单药治疗该组患者效果欠佳,需进一步研究优化管理。
核心结论
- 有脑膜炎症状的隐球菌抗原血症是第三常见脑膜炎病因,推测为早期隐球菌性脑膜脑炎。
- 尽管脑脊液隐球菌抗原阴性,氟康唑单药治疗仍不理想。
研究设计与样本
- 在乌干达坎帕拉和姆巴拉拉评估1201例HIV血清阳性疑似脑膜炎住院患者。
主要发现
- 56%(671/1201)为确诊脑脊液隐球菌抗原阳性脑膜炎,4%(54/1201)为有神经系统症状但脑脊液隐球菌抗原阴性。
- 脑脊液抗原阴性者中9%(5/54)通过培养(n=3)或PCR(n=2)分离出隐球菌,11%(6/54)确诊结核性脑膜炎。
- 脑脊液抗原阴性者脑脊液细胞增多(≥5个白细胞/μL)比例为16% vs 26%,开放压力>200 mmH2O比例为16% vs 71%,均低于抗原阳性者。
- 脑脊液PCR或培养未检出细菌性或病毒性脑膜炎病例。
关键数值与推荐
- 脑脊液隐球菌抗原阴性者中9%(5/54)经培养或PCR检出隐球菌。
- 脑脊液隐球菌抗原阴性者中11%(6/54)确诊结核性脑膜炎。
- 脑脊液细胞增多(≥5个白细胞/μL)比例:抗原阴性16% vs 抗原阳性26%。
- 脑脊液开放压力>200 mmH2O比例:抗原阴性16% vs 抗原阳性71%。
临床怎么用
- 对HIV阳性疑似脑膜炎患者应检测脑脊液隐球菌抗原,抗原阴性但血抗原阳性且有症状者需警惕早期隐球菌性脑膜脑炎。
- 该组患者氟康唑单药治疗不理想,需进一步研究优化抗真菌方案。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection to cryptococcal meningitis is unclear. We describe a subpopulation of individuals with neurologic symptomatic cryptococcal antigenemia but negative cerebral spinal fluid (CSF) studies. METHODS: We evaluated 1201 human immunodeficiency virus-seropositive individuals hospitalized with suspected meningitis in Kampala and Mbarara, Uganda. Baseline characteristics and clinical outcomes of participants with neurologic-symptomatic cryptococcal antigenemia and negative CSF cryptococcal antigen (CrAg) were compared to participants with confirmed CSF CrAg+ cryptococcal meningitis. Additional CSF testing included microscopy, fungal culture, bacterial culture, tuberculosis culture, multiplex FilmArray polymerase chain reaction (PCR; Biofire), and Xpert MTB/Rif. RESULTS: We found 56% (671/1201) of participants had confirmed CSF CrAg+ cryptococcal meningitis and 4% (54/1201) had neurologic symptomatic cryptococcal antigenemia with negative CSF CrAg. Of those with negative CSF CrAg, 9% (5/54) had Cryptococcus isolated on CSF culture (n = 3) or PCR (n = 2) and 11% (6/54) had confirmed tuberculous meningitis. CSF CrAg-negative patients had lower proportions with CSF pleocytosis (16% vs 26% with ≥5 white cells/μL) and CSF opening pressure >200 mmH2O (16% vs 71%) compared with CSF CrAg-positive patients. No cases of bacterial or viral meningitis were detected by CSF PCR or culture. In-hospital mortality was similar between symptomatic cryptococcal antigenemia (32%) and cryptococcal meningitis (31%; P = .91). CONCLUSIONS: Cryptococcal antigenemia with meningitis symptoms was the third most common meningitis etiology. We postulate this is early cryptococcal meningoencephalitis. Fluconazole monotherapy was suboptimal despite Cryptococcus-negative CSF. Further studies are warranted to understand the clinical course and optimal management of this distinct entity. CLINICAL TRIALS REGISTRATION: NCT01802385.
引用
- Ssebambulidde K, Bangdiwala AS, Kwizera R, et al. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis. Clin Infect Dis. 2019. PMID: 30256903. doi:10.1093/cid/ciy817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。